Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jacobson D.H., Gorman C.A. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr. Rev. 5: 200, 1984.
McConahey W.M. Medical therapy. In: Gorman C.A., Waller R.R., Dyer J.A., (Eds.), The eye and orbit in Graves’ disease. Raven Press New York: 1984, p. 317.
Pinchera A., Bartalena L., Chiovato L., Marcocci C. Radiotherapy of Graves’ ophthalmopathy. In: Gorman C.A., Waller R.R., Dyer J.A., (Eds.), The eye and orbit in Graves’ disease. Raven Press New York: 1984, p. 301.
Pinchera A., Bartalena L., Marcocci C., Ceccarelli P., Cucchi P., Vitti P., Mariotti S., Fenzi G.F. Humoral autoimmunity in endocrine ophthalmopathy. Acta Endocrinol. (Copenh) 121(Suppl. 2): 112, 1989.
Kriss J.P. Pathogenesis and treatment of Graves’ ophthalmopathy. Thyroid Today 7: 1, 1984.
Bartalena L., Marcocci C., Chiovato L., Laddaga M., Lepri G., Andreani D., Cavallacci G., Baschieri L., Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab. 56: 1139, 1983.
Kriss J.P., Petersen I.A., Donaldson S.S., McDougall I.R. Supervoltage orbital radiotherapy for progressive Graves’ ophthalmopathy: results of a twenty-year experience. Acta Endocrinol. (Copenh.) 121(Suppl 2): 154, 1989.
Werner S.C. Modification of the classification of the eye changes of Graves’ disease: recommendations of the ad hoc Committee of the American Thyroid Association. J. Clin. Endocrinol. Metab. 44: 203, 1977.
Donaldson S.S., Bagshaw M.A., Kriss J.P. Supervoltage orbital radiotherapy for Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 37: 276, 1983.
Marcocci C., Bartalena L., Panicucci M., Marconcini C., Cartei F., Cavallacci G., Laddaga M., Campobasso G., Baschieri L., Pinchera A. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves’ ophthalmopathy: a comparative study. Clin. Endocrinol. (Oxf.) 27: 33, 1987.
Mourits M., Koornneef L., Wiersinga W.M., Prummel M.F., Berghout A., van der Gaag R. Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73: 639, 1989.
Brown J., Coburn J.W., Wigod R.A., Hiss J.M., Dowling J.T. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves’ disease. Am. J. Med. 34: 786, 1963.
Kahaly G., Schrezenmeir J., Krause U. Ciclosporin and prednisone v. prednisone in the treatment of Graves’ ophthalmopathy: a controlled, randomized and prospective study. Eur. J. Clin. Invest. 16: 415–22, 1986.
Covington E.E., Lobes L., Sudarsanam A. Radiation therapy of exophthalmos: report of seven cases. Radiology 122: 797, 1976.
Olivotto A., Ludgate C.M., Allen L.H., Rootman J. Supervoltage radiotherapy for Graves’ ophthalmopathy: CCABC technique and results. Int. J. Radiat. Oncol. Biol. Phys. 11: 2085, 1985.
Bartalena L., Marcocci C., Bogazzi F., Panicucci M., Lepri A., Pinchera A. Use of corticosteroids to prevent progression of Graves’ ophthalmopathy after radioiodine therapy for hyperthyroidism. N. Engl. J. Med. 321: 1349, 1989.
Bartalena L., Marcocci C., Bogazzi F., Bruno-Bossio G., Pinchera A. Glucocorticoid therapy of Graves’ ophthalmopathy. Exp. Clin. Endocrinol. 97: 320, 1991.
Marcocci C., Bartalena L., Bogazzi F., Bruno-Bossio G., Pinchera A. Role of orbital radio therapy in the treatment of Graves’ opthalmopathy. Exp. Clin. Endocrinol. 97: 332, 1991.
Bartalena L., Marcocci C., Bogazzi F. A new ophthalmopathy index for quantitation of eye changes of Graves’ disease. Acta Endocrinol. (Copenh.) 121(Suppl 2): 190, 1989.
Bahn R.S., Garrity J.A., Bartley G.B., Gorman C.A. Diagnostic evaluation of Graves’ ophthalmopathy. Endocrinol. Metab. Clin. North. Am. 17: 527, 1988.
Brennan M.W., Leone C.R., Janaki L. Radiation therapy for Graves’ disease. Am. J. Ophtalmol. 96: 195, 1983.